20636 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
MODIFIED PORCINE CELLS AND METHODS OF USING THE SAME
#2ADHESION MOLECULE INHIBITION FOR STEM CELL THERAPIES
#3PHARMACEUTICAL COMPOSITION CONTAINING CBFbeta-EXPRESSING VASCULAR SMOOTH MUSCLE CELLS OR CULTURE FLUID THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AGE-RELATED DISEASES
#4THERAPEUTIC HYDROGEL DEVICE
#5METHOD FOR PRODUCING CELL AGGREGATES
#6STEM CELL AND SOMATIC CELL REPROGRAMMING WITH GENE ENHANCED STEM CELLS TO RESTORE AGE RELATED FOR PHYSICAL FUNCTIONS TO EXTEND LONGEVITY
#7CORD BLOOD-DERIVED VASCULAR ENDOTHELIAL PROGENITOR CELL AND COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASE CONTAINING SAME
#8METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#9COMPOSITIONS COMPRISING PREVASCULARIZED ORGANOIDS AND METHODS FOR ENHANCING ANGIOGENESIS
#10HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME
#11Vascular Constructs
#12LUNG BIOREACTOR
#13LEVERAGING TYPE 2 CYTOKINES TO ENHANCE CELL-BASED THERAPY FOR PERIPHERAL ARTERIAL DISEASES
#14METHOD OF PRODUCING STEM CELL-DERIVED ENDOTHELIAL CELLS AND USES THEREOF
#15METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#16Methods and Compositions for Tissue Regeneration
#17CELL POPULATIONS OF CD31-POSITIVE, CD45-NEGATIVE, CD200-POSITIVE MAMMALIAN CELLS AND USE THEREOF
#18BONE MARROW ORGANOIDS PRODUCED FROM INDUCED PLURIPOTENT STEM CELLS AND USES OF THESE ORGANOIDS
#19Generating Vasculogenic Cell Populations
#20ENHANCED GENE DELIVERY METHODS
#21METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND VASCULOGENESIS
#22PERICYTES FOR USE AS A MEDICAMENT
#23HYPOIMMUNOGENIC STEM CELLS, HYPOIMMUNOGENIC CELLS DIFFERENTIATED OR DERIVED FROM STEM CELLS AND METHOD OF PREPARING SAME
#24Autophagosome For Promoting Healing of Diabetic Wound, and Preparation Method and Use Thereof
#25GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY TO REDUCE COMPLEMENT-MEDIATED INFLAMMATORY REACTIONS
#26miRNA REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLS
#27ENDOTHELIAL CELL FACTORS AND METHODS THEREOF
#28GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY
#29VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)-HIGHLY EXPRESSING PERICYTE-LIKE CELL
#30METHODS FOR SCREENING GENETIC PERTURBATIONS
#31METHOD FOR PRODUCING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)- HIGHLY EXPRESSING PERICYTE-LIKE CELL
#32Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof
#33Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic Agents
#34MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#35COMPOSITION CONTAINING MESENCHYMAL STEM CELL AND VASCULAR ENDOTHELIAL PROGENITOR CELL AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCCLUSIVE VASCULAR DISEASE OR COMPLICATION THEREOF
#36PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN
#37MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#38COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND USE THEREOF
#39METHODS OF RESTORING FUNCTIONAL CAPACITY AND LINEAGE COMPOSITION OF AN AGING BLOOD AND VASCULAR SYSTEM
#40Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
#41MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#42LUNG BIOREACTOR
#43METHOD FOR PREPARING BONE-MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS HAVING INCREASED VASCULOGENESIS BY USING PDGF-BB, AND METHOD FOR PREPARING CELL THERAPEUTIC AGENT FOR TREATING ANANGIOPLASIA-RELATED DISEASES BY USING METHOD
#44COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE
#45GENERATING ARTERIAL ENDOTHELIAL CELL POPULATIONS
#46Method to Improve Therapeutic Properties of Stem Cells
#47METHODS AND COMPOSITIONS FOR STEM CELL TRANSPLANTATION
#48INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION
#49HEMANGIO-COLONY FORMING CELLS
#50UMBILICAL CORD PRODUCTS
#51Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
#52PERFORATED TISSUE GRAFT
#53ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED TOXICITY
#54Microvascular endothelial cell comprising a nucleic acid encoding an anti-TDP-43 fab
#55BIOMATERIALS FOR ENHANCED IMPLANT-HOST INTEGRATION
#56Cell sheet construct for neurovascular reconstruction and manufacture thereof
#57COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER
#58METHOD OF GENERATING ENDOTHELIAL CELLS
#59ENGINEERED TISSUE CONSTRUCTS
#60SAFETY SWITCHES FOR REGULATION OF GENE EXPRESSION
#61TISSUE ENGINEERED VASCULAR GRAFTS WITH ADVANCED MECHANICAL STRENGTH
#62MANUFACTURE AND CRYOPRESERVATION OF FUCOSYLATED CELLS FOR THERAPEUTIC USE
#63Lung bioreactor
#64BONE REPAIR COMPOSITIONS
#65GENERATION OF KIDNEY GLOMERULAR SPECIFIC ENDOTHELIAL CELLS AND METHODS OF USE
#66EXOSOMES FROM CLONAL PROGENITOR CELLS
#67PERICYTE CELL EXOSOMES
#68FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE
#69Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type
#70METHOD OF ISOLATION OF PURE CULTURE OF VASCULAR ENDOTHELIAL CELLS, MEDIUM FOR MAINTAINING CHARACTERISTICS OF VASCULAR ENDOTHELIAL CELLS, AND CULTURE METHOD INCLUDING SAME
#71FIBROBLAST-BASED THERAPY FOR TREATMENT OF SCLEROSING CHOLANGITIS
#72ENDOTHELIAL AND SMOOTH MUSCLE LIKE TISSUE PRODUCED FROM URINE CELLS AND USES RELATED THERETO
#73CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS
#74COMPOSITIONS FOR THE TREATMENT OF NEUROPATHIC PAIN AND SENSITIZATION OF TUMORS TO CHEMOTHERAPIES
#75Compositions and methods for treating and preventing tissue injury and disease
#76CELLULAR SEEDING AND CO-CULTURE OF A THREE DIMENSIONAL FIBROBLAST CONSTRUCT
#77LOW OXYGEN TENSION ENHANCES ENDOTHELIAL FATE OF HUMAN PLURIPOTENT STEM CELLS
#78COMPOSITIONS AND METHODS OF TREATING VASCULAR DISEASES
#79METHODS OF TREATING VASCULAR DISEASES
#80ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USES THEREOF
#81COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER
#82Method for producing marine algae-derived agarotriose, and use thereof as prebiotic
#83COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM
#84COMPOSITIONS AND METHODS FOR THYMIC REGENERATION AND T-CELL RECONSTITUTION
#85ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
#86Methods and compositions for modulating angiogenesis and vasculogenesis
#87THERAPEUTIC HYDROGEL DEVICE
#88Extracellular Matrices, Uses Thereof, and Methods of Making Extracellular Matrices
#89Method for integrating biological tissues with a vascular system
#90PREPARATION AND EXTENDED CULTURE OF VASCULAR ENDOTHELIAL PROGENITOR CELL
#91MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION
#92METHOD FOR IMPROVING ANGIOGENIC POTENTIAL OF A MESENCHYMAL STEM CELL
#93Production method for retinal tissue
#94MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#95MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#96COMPOSITION FOR TREATING BLOOD COAGULATION AND/OR COMPLEMENT DISORDERS
#97PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR DISEASES ACCOMPANIED BY FIBROSIS
#98Organ enclosures for inhibiting tumor invasion and detecting organ pathology
#99Bioabsorbable stent system
#100Method of solubilizing TDP-43 protein aggregates in amyotrophic lateral sclerosis using a microvascular endothelial cell expressing an anti-TDP-43 Fab
#101METHODS AND COMPOSITIONS FOR TREATMENT OF TYPE 1 DIABETES USING FIBROBLASTS AS FACILITATORS OF ISLET ENGRAFTMENT
#102METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME
#103A METHOD FOR INCREASING POPULATION OF SPERMATOGONIAL STEM CELLS
#104Generating vasculogenic cell populations
#105METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF
#106MACROMOLECULAR CLUSTERS OF CARDIAC STEM CELLS AND METHODS FOR MAKING AND USING THEM
#107MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#108MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#109Blood-brain barrier comprising engineered endothelial cells
#110Vascular constructs
#111METHODS FOR ORGAN REGENERATION
#112Biomaterials for enhanced implant-host integration
#113Electrical stimulation of cells to induce enhanced secretome for therapeutic applications
#114HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME
#115ADIPOSE TISSUE PARTICLE PROCESSING, TRANSFER AND STORAGE SYSTEM
#116Targeting Mirnas for Exosomal Delivery or Cellular Retention
#117METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#118CELLULAR AGGREGATES FOR USE IN VASCULARISATION THERAPY
#119Method For Obtaining Differentiated Cells From Muscle Derived Progenitor Cells
#120Methods for screening genetic perturbations
#121MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#122Endothelial cell factors and methods thereof
#123Compositions and Methods for Treatment of Cardiovascular Disorders
#124Exosome active formulation for inhibiting endothelial cell migration, and preparation method and application
#125Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
#126ANGIOGENESIS-INDUCING METHOD USING NEURAL STEM CELL
#127Exosome active formulation for promoting endothelial cell angiogenesis, and preparation method and application
#128FREE-STANDING, TRANSFERRABLE VASCULAR NETWORKS VIA GUIDED SELF-ASSEMBLY AND USE IN CELL REPLACEMENT THERAPIES
#129Compositions and methods for treating and/or preventing sepsis and/or inflammatory conditions
#130ROBUST DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS INTO ENDOTHELIAL CELLS USING TRANSCRIPTION FACTOR ETV2
#131Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof
#132COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION
#133THREE-DIMENSIONAL DIFFERENTIATION OF EPIBLAST SPHEROIDS TO KIDNEY ORGANOIDS MODELS STAGE-SPECIFIC EPITHELIAL PHYSIOLOGY, MORPHOGENESIS, AND DISEASE
#134Methods for Vascular Construction and Products Therefrom
#135COMPOSITIONS AND METHODS FOR TREATING NERVE INJURY
#136Method for tissue regeneration using cancer cell-derived exosomes
#137Compositions and methods for treating and preventing tissue injury and disease
#138Biological Scaffold Comprising Therapeutic Cells
#139HLA G-MODIFIED CELLS AND METHODS
#140METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#141PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS
#142MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME
#143Method to improve therapeutic properties of stem cells
#144Non-covalently assembled conductive hydrogel
#145Indirect ultrasonic cavitation-derived perivascular cells and methods of use thereof
#146COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE
#147HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS
#148Bioengineered allogeneic blood vessel
#149Composition derived from mammalian umbilical cord and Whartons jelly for use in therapeutic and regenerative applications
#150Cell sheet construct for neurovascular reconstruction and manufacture thereof
#151Cell sheet construct for neurovascular reconstruction and manufacture thereof
#152Methods and compositions for treatment of eye conditions
#153Composition and methods for inducing myeloid suppressive cells and use thereof
#154Biomaterials for enhanced implant-host integration
#155OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM
#156ELESTOMERIC FIBROUS HYBRID SCAFFOLD FOR IN VITRO AND IN VIVO FORMATION
#157METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME
#158Tissue constructs including pancreas derived microvessel fragments and related methods
#159Compositions and methods for treating a clinical condition through the use of hematopoietic stem cells
#160HLA G-modified cells and methods
#161IDENTIFICATION, ISOLATION, AND THERAPEUTIC USES OF ENDOTHELIAL STEM CELLS THAT EXPRESS THE ABCG2+ SURFACE MARKER
#162MAGNETIC CELLS FOR LOCALIZING DELIVERY AND TISSUE REPAIR
#163COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER
#164Increased cell retention in diseased site when cells encapsulated in gelatin methacrylate and polyethylene glycol diacrylate hydrogels
#165Stable three-dimensional blood vessels and methods for forming the same
#166REGULATING STEM CELLS
#167In vitro production of muscle stem cells
#168ENGINEERING BLOOD VESSEL CELLS FOR TRANSPLANTATION
#169Methods of Treating Brain Injury Using Cord Blood or a Component Thereof
#170FROZEN THERAPEUTIC DOSE AND PACKAGE
#171ENGINEERED BLOOD VESSELS
#172MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#173Methods to enhance microvascular engraftment of bioengineered and primary tissues
#174Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial Cells
#175Exosomes from clonal progenitor cells
#176Compositions for the treatment of neuropathic pain and sensitization of tumors to chemotherapies
#177Methods and compositions for modulating angiogenesis and vasculogenesis
#178Method of isolating cells for therapy and prophylaxis
#179PERICYTE CELL EXOSOMES
#180P53 SILENCED ENDOTHELIAL PROGENITOR CELLS FOR DIABETES
#181Engineered Lumenized Vascular Networks and Support Matrix
#182Vascular constructs
#183Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells
#184Methods for the treatment of cardiac hypertrophy
#185Customized hybrid bone-implant grafts
#186SYSTEMICALLY AND LOCALLY ADMINISTERED CELLS FOR NEUROPATHIC PAIN
#187Microfluidics device for fabrication of large, uniform, injectable hydrogel microparticles for cell encapsulation
#188Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use
#189hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
#190Process for obtaining a sprinkling compound of microvascular endothelial skin cells and mesenchymal stem cells and method of application for tissue regeneration
#191Hemangio-colony forming cells
#192ELASTIC TISSUE MATRIX DERIVED HYDROGEL
#193Regulation of mesodermal specification
#194Treatment of pulmonary arterial hypertension with mesenchymal stem cells
#195DECELLULARIZED SOFT-TISSUE GRAFTS
#196HUCBC TREATMENT OF AMYLOID-ASSOCIATED DISEASE
#197MAPC treatment of brain injuries and diseases
#198Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#199METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME
#200Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
#201NANOPARTICLE BASED TUMOR ENDOTHELIAL TARGETING VACCINE
#202A COMPOSITION OF GOLD NANOPARTICLES HAVING ANTIMICROBIAL PEPTIDES BOUND ON THEIR SURFACE FOR USE THE TREATMENT OF WOUND HEALING OR IN THE TREATMENT OF ISCHEMIC OR VASCULAR DISEASES OR IN THE TREATMENT OF SKIN DISORDERS
#203Perforated tissue graft
#204Three-dimensional differentiation of epiblast spheroids to kidney organoids models stage-specific epithelial physiology, morphogenesis, and disease
#205ANTI-THROMBOGENIC GRAFTS
#206Cellular seeding and co-culture of a three dimensional fibroblast construct
#207Engineered platforms to stabilize both hepatocytes and endothelial cells in vitro
#208SCAFFOLD FOR GROWING NEURONAL CELLS AND TISSUE
#209Vascular cast-based scaffolds and methods of making the same
#210Method for inducing vascular endothelial cells
#211IPSC-EC PERFORMANCE ENHANCEMENT VIA SIRT1 OVEREXPRESSION
#212Engineered endothelial cells expressing an ETS transcription factor
#213TRANSGENIC PIGS WITH GENETIC MODIFICATIONS OF SLA
#214ENGINEERED MODEL OF FIBROTIC DISEASES
#215Compositions and methods for treating and preventing tissue injury and disease
#216COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION
#217Magnetic cells for localizing delivery and tissue repair
#218Compositions and methods for treatment of cardiovascular disorders
#219Cell structure and method for producing cell structure
#220Method of Producing Stem Cell-Derived Endothelial Cells and Uses Thereof
#221Generating vasculogenic cell populations
#222MAPC treatment of brain injuries and diseases
#223Iron platinum particles for adherence of biologics on medical implants
#224METHODS AND COMPOSITIONS FOR MODIFYING ENDOTHELIAL CELLS
#225Engineered tissue constructs
#226MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#227Bioengineered allogeneic blood vessel
#228METASTATIC CANCER DECOY TRAP
#229Injectable microtissue systems, devices, and methods
#230COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS
#231MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#232Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
#233Pouch-like structure with paracrine activity and method for its preparation
#234OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM
#235Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
#236Compositions and methods for treating and preventing tissue injury and disease
#237PHOTOACTIVATABLE CAGED TAMOXIFEN AND TAMOXIFEN DERIVATIVE MOLECULES AND METHODS OF USE THEREOF
#238Method for producing therapeutic corneal endothelial substitute cell sphere
#239Artificial tissue and method for producing same
#240Treatment of cornea using laminin
#241Production method for retinal tissue
#242Pericytes are intermediate progenitors for epicardial derived coronary artery smooth muscle
#243HLA G-modified cells and methods
#244Method for preparing a biological tissue construct and use of autologous cells obtained specifically
#245Methods and compositions for modulating angiogenesis and vasculogenesis
#246Cardiomyocyte maturation platform
#247Combination immunotherapy approach for treatment of cancer
#248METHOD OF CULTURING CELLS
#249Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto
#250HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS
#251Composition for inducing direct transdifferentiation of somatic cell into vascular progenitor cell, and use thereof
#252METHODS AND COMPOSITIONS TO SUPPORT TRANSPLANTED TISSUE INTEGRATION AND INOSCULATION WITH ADIPOSE STROMAL CELLS
#253Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use
#254Frozen therapeutic dose and package
#255Methods and compositions for vein harvest and autografting
#256Bone repair compositions
#257Silk-based scaffold platform for engineering tissue constructs
#258Method for generating endothelial colony forming cell-like cells
#259Lung bioreactor
#260Low oxygen tension enhances endothelial fate of human pluripotent stem cells
#261Use of cells derived from first trimester umbilical cord tissue
#262MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME
#263Cardiac, mesenchymal and endothelial progenitor cell (CPC) chimeras and methods for making and using them
#264Combined agent for cell therapy of corneal endothelial cell
#265Methods of using regenerative cells to promote epithelialization or neodermis formation
#266HUCBC treatment of amyloid-associated disease
#267Therapeutic agents and delivery with microspheres
#268Method for preparing of endothelial cells by transformation (transdifferentiation) of adult fibroblast, and use thereof
#269Generating arterial endothelial cell populations
#270Tissue engineered devices and methods for making same
#271Bone marrow origin progenitor cell or endothelial progenitor cell in combination with DNMT1 gene therapy for vascular repair in metabolic disease
#272Method of treatment utilizing an acellular amnion derived therapeutic composition
#273Process for enhancing stem cell bioactivity using tauroursodeoxycholic acid
#274METHOD FOR INTEGRATING BIOLOGICAL TISSUES WITH A VASCULAR SYSTEM
#275Flk1+ and VE-Cadherin+ Endothelial Cells Derived from iPS or ES Cells, and Methods of Preparing and Using the Same
#276Engineered lumenized vascular networks and support matrix
#277MACROMOLECULAR CLUSTERS OF CARDIAC STEM CELLS AND METHODS FOR MAKING AND USING THEM
#278Regulating stem cells
#279Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues
#280Compositions And Methods For The Treatment Of Tinnitus
#281Hemangio-colony forming cells
#282Exosomes from clonal progenitor cells
#283ORGANOIDS COMPRISING ISOLATED RENAL CELLS AND USE THEREOF
#284METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#285Formulation for Accelerating Wound Healing, Preparation Method and Administering Method of The Same
#286Anti-thrombogenic grafts
#287MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOF
#288Bioengineered allogeneic blood vessel
#289Method of isolating cells for therapy and prophylaxis
#290CARDIAC OR VASCULAR TISSUE SPHEROID
#291Method of treatment for pulpitis and/or enhancement for dentinogenesis
#292Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#293Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
#294Perivascular mesenchymal precursor cells
#295Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors
#296Growth factor sequestering and presenting hydrogels
#297Modalities for the treatment of degenerative diseases of the retina
#298Endothelial and endothelial like cells produced from fibroblasts and uses related thereto
#299Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
#300INHIBITION OF RHO AND OR ROCK AND CELL TRANSPLANTATION